دورية أكاديمية
أعرض في EDS

Association of prestroke metformin use, stroke severity, and thrombolysis outcome.

التفاصيل البيبلوغرافية
العنوان: Association of prestroke metformin use, stroke severity, and thrombolysis outcome.
المؤلفون: Westphal, L.P., Widmer, R., Held, U., Steigmiller, K., Hametner, C., Ringleb, P., Curtze, S., Martinez-Majander, N., Tiainen, M., Nolte, C.H., Scheitz, J.F., Erdur, H., Polymeris, A.A., Traenka, C., Eskandari, A., Michel, P., Heldner, M.R., Arnold, M., Zini, A., Vandelli, L., Coutinho, J.M., Groot, A.E., Padjen, V., Jovanovic, D.R., Bejot, Y., Brenière, C., Turc, G., Seners, P., Pezzini, A., Magoni, M., Leys, D., Gilliot, S., Scherrer, M.J., Kägi, G., Luft, A.R., Gensicke, H., Nederkoorn, P., Tatlisumak, T., Engelter, S.T., Wegener, S.
المساهمون: Thrombolysis in Ischemic Stroke Patients (TRISP) Study Group
المصدر: Neurology, vol. 95, no. 4, pp. e362-e373
سنة النشر: 2020
المجموعة: Université de Lausanne (UNIL): Serval - Serveur académique lausannois
مصطلحات موضوعية: Aged, Diabetes Mellitus, Type 2/drug therapy, Female, Fibrinolytic Agents/therapeutic use, Humans, Hypoglycemic Agents/therapeutic use, Male, Metformin/therapeutic use, Middle Aged, Recovery of Function/drug effects, Retrospective Studies, Stroke/drug therapy, Stroke/mortality, Stroke/physiopathology, Thrombolytic Therapy/methods
الوصف: To evaluate whether pretreatment with metformin (MET) is associated with less stroke severity and better outcome after IV thrombolysis (IVT), we analyzed a cohort of 1,919 patients with stroke with type 2 diabetes mellitus in a multicenter exploratory analysis. Data from patients with diabetes and ischemic stroke treated with IVT were collected within the European Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration. We applied propensity score matching (PSM) to obtain balanced baseline characteristics of patients treated with and without MET. Of 1,919 patients with stroke with type 2 diabetes who underwent IVT, 757 (39%) had received MET before stroke (MET+), whereas 1,162 (61%) had not (MET-). MET+ patients were younger with a male preponderance. Hypercholesterolemia and pretreatment with statins, antiplatelets, or antihypertensives were more common in the MET+ group. After PSM, the 2 groups were well balanced with respect to demographic and clinical aspects. Stroke severity on admission (NIH Stroke Scale 10.0 ± 6.7 vs 11.3 ± 6.5), 3-month degree of independence on modified Rankin Scale (2 [interquartile range (IQR) 1.0-4.0] vs 3 [IQR 1.0-4.0]), as well as mortality (12.5% vs 18%) were significantly lower in the MET+ group. The frequency of symptomatic intracerebral hemorrhages did not differ between groups. HbA1c levels were well-balanced between the groups. Patients with stroke and diabetes on treatment with MET receiving IVT had less severe strokes on admission and a better functional outcome at 3 months. This suggests a protective effect of MET resulting in less severe strokes as well as beneficial thrombolysis outcome.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0028-3878
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32601121; info:eu-repo/semantics/altIdentifier/eissn/1526-632X; https://serval.unil.ch/notice/serval:BIB_60D5FF42E716Test; urn:issn:0028-3878
DOI: 10.1212/WNL.0000000000009951
الإتاحة: https://doi.org/10.1212/WNL.0000000000009951Test
https://serval.unil.ch/notice/serval:BIB_60D5FF42E716Test
رقم الانضمام: edsbas.A922C6C8
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.A922C6C8
848
3
Academic Journal
academicJournal
847.616333007813
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.A922C6C8&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1212/WNL.0000000000009951# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Association of prestroke metformin use, stroke severity, and thrombolysis outcome. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Westphal%2C+L%2EP%2E%22">Westphal, L.P.</searchLink><br /><searchLink fieldCode="AR" term="%22Widmer%2C+R%2E%22">Widmer, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Held%2C+U%2E%22">Held, U.</searchLink><br /><searchLink fieldCode="AR" term="%22Steigmiller%2C+K%2E%22">Steigmiller, K.</searchLink><br /><searchLink fieldCode="AR" term="%22Hametner%2C+C%2E%22">Hametner, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Ringleb%2C+P%2E%22">Ringleb, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Curtze%2C+S%2E%22">Curtze, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Martinez-Majander%2C+N%2E%22">Martinez-Majander, N.</searchLink><br /><searchLink fieldCode="AR" term="%22Tiainen%2C+M%2E%22">Tiainen, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Nolte%2C+C%2EH%2E%22">Nolte, C.H.</searchLink><br /><searchLink fieldCode="AR" term="%22Scheitz%2C+J%2EF%2E%22">Scheitz, J.F.</searchLink><br /><searchLink fieldCode="AR" term="%22Erdur%2C+H%2E%22">Erdur, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Polymeris%2C+A%2EA%2E%22">Polymeris, A.A.</searchLink><br /><searchLink fieldCode="AR" term="%22Traenka%2C+C%2E%22">Traenka, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Eskandari%2C+A%2E%22">Eskandari, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Michel%2C+P%2E%22">Michel, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Heldner%2C+M%2ER%2E%22">Heldner, M.R.</searchLink><br /><searchLink fieldCode="AR" term="%22Arnold%2C+M%2E%22">Arnold, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Zini%2C+A%2E%22">Zini, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Vandelli%2C+L%2E%22">Vandelli, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Coutinho%2C+J%2EM%2E%22">Coutinho, J.M.</searchLink><br /><searchLink fieldCode="AR" term="%22Groot%2C+A%2EE%2E%22">Groot, A.E.</searchLink><br /><searchLink fieldCode="AR" term="%22Padjen%2C+V%2E%22">Padjen, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Jovanovic%2C+D%2ER%2E%22">Jovanovic, D.R.</searchLink><br /><searchLink fieldCode="AR" term="%22Bejot%2C+Y%2E%22">Bejot, Y.</searchLink><br /><searchLink fieldCode="AR" term="%22Brenière%2C+C%2E%22">Brenière, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Turc%2C+G%2E%22">Turc, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Seners%2C+P%2E%22">Seners, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Pezzini%2C+A%2E%22">Pezzini, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Magoni%2C+M%2E%22">Magoni, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Leys%2C+D%2E%22">Leys, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Gilliot%2C+S%2E%22">Gilliot, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Scherrer%2C+M%2EJ%2E%22">Scherrer, M.J.</searchLink><br /><searchLink fieldCode="AR" term="%22Kägi%2C+G%2E%22">Kägi, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Luft%2C+A%2ER%2E%22">Luft, A.R.</searchLink><br /><searchLink fieldCode="AR" term="%22Gensicke%2C+H%2E%22">Gensicke, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Nederkoorn%2C+P%2E%22">Nederkoorn, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Tatlisumak%2C+T%2E%22">Tatlisumak, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Engelter%2C+S%2ET%2E%22">Engelter, S.T.</searchLink><br /><searchLink fieldCode="AR" term="%22Wegener%2C+S%2E%22">Wegener, S.</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Thrombolysis in Ischemic Stroke Patients (TRISP) Study Group )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Neurology, vol. 95, no. 4, pp. e362-e373 )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2020 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Université de Lausanne (UNIL): Serval - Serveur académique lausannois )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+Mellitus%22">Diabetes Mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22Type+2%2Fdrug+therapy%22">Type 2/drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Fibrinolytic+Agents%2Ftherapeutic+use%22">Fibrinolytic Agents/therapeutic use</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Hypoglycemic+Agents%2Ftherapeutic+use%22">Hypoglycemic Agents/therapeutic use</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Metformin%2Ftherapeutic+use%22">Metformin/therapeutic use</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Recovery+of+Function%2Fdrug+effects%22">Recovery of Function/drug effects</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+Studies%22">Retrospective Studies</searchLink><br /><searchLink fieldCode="DE" term="%22Stroke%2Fdrug+therapy%22">Stroke/drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Stroke%2Fmortality%22">Stroke/mortality</searchLink><br /><searchLink fieldCode="DE" term="%22Stroke%2Fphysiopathology%22">Stroke/physiopathology</searchLink><br /><searchLink fieldCode="DE" term="%22Thrombolytic+Therapy%2Fmethods%22">Thrombolytic Therapy/methods</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => To evaluate whether pretreatment with metformin (MET) is associated with less stroke severity and better outcome after IV thrombolysis (IVT), we analyzed a cohort of 1,919 patients with stroke with type 2 diabetes mellitus in a multicenter exploratory analysis. Data from patients with diabetes and ischemic stroke treated with IVT were collected within the European Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration. We applied propensity score matching (PSM) to obtain balanced baseline characteristics of patients treated with and without MET. Of 1,919 patients with stroke with type 2 diabetes who underwent IVT, 757 (39%) had received MET before stroke (MET+), whereas 1,162 (61%) had not (MET-). MET+ patients were younger with a male preponderance. Hypercholesterolemia and pretreatment with statins, antiplatelets, or antihypertensives were more common in the MET+ group. After PSM, the 2 groups were well balanced with respect to demographic and clinical aspects. Stroke severity on admission (NIH Stroke Scale 10.0 ± 6.7 vs 11.3 ± 6.5), 3-month degree of independence on modified Rankin Scale (2 [interquartile range (IQR) 1.0-4.0] vs 3 [IQR 1.0-4.0]), as well as mortality (12.5% vs 18%) were significantly lower in the MET+ group. The frequency of symptomatic intracerebral hemorrhages did not differ between groups. HbA1c levels were well-balanced between the groups. Patients with stroke and diabetes on treatment with MET receiving IVT had less severe strokes on admission and a better functional outcome at 3 months. This suggests a protective effect of MET resulting in less severe strokes as well as beneficial thrombolysis outcome. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 0028-3878 )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/32601121; info:eu-repo/semantics/altIdentifier/eissn/1526-632X; https://serval.unil.ch/notice/serval:BIB_60D5FF42E716; urn:issn:0028-3878 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1212/WNL.0000000000009951 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1212/WNL.0000000000009951<br />https://serval.unil.ch/notice/serval:BIB_60D5FF42E716 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.A922C6C8 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1212/WNL.0000000000009951 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Aged [Type] => general ) [1] => Array ( [SubjectFull] => Diabetes Mellitus [Type] => general ) [2] => Array ( [SubjectFull] => Type 2/drug therapy [Type] => general ) [3] => Array ( [SubjectFull] => Female [Type] => general ) [4] => Array ( [SubjectFull] => Fibrinolytic Agents/therapeutic use [Type] => general ) [5] => Array ( [SubjectFull] => Humans [Type] => general ) [6] => Array ( [SubjectFull] => Hypoglycemic Agents/therapeutic use [Type] => general ) [7] => Array ( [SubjectFull] => Male [Type] => general ) [8] => Array ( [SubjectFull] => Metformin/therapeutic use [Type] => general ) [9] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [10] => Array ( [SubjectFull] => Recovery of Function/drug effects [Type] => general ) [11] => Array ( [SubjectFull] => Retrospective Studies [Type] => general ) [12] => Array ( [SubjectFull] => Stroke/drug therapy [Type] => general ) [13] => Array ( [SubjectFull] => Stroke/mortality [Type] => general ) [14] => Array ( [SubjectFull] => Stroke/physiopathology [Type] => general ) [15] => Array ( [SubjectFull] => Thrombolytic Therapy/methods [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Association of prestroke metformin use, stroke severity, and thrombolysis outcome. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Westphal, L.P. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Widmer, R. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Held, U. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Steigmiller, K. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hametner, C. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ringleb, P. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Curtze, S. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Martinez-Majander, N. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tiainen, M. ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nolte, C.H. ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Scheitz, J.F. ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Erdur, H. ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Polymeris, A.A. ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Traenka, C. ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Eskandari, A. ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Michel, P. ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Heldner, M.R. ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Arnold, M. ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zini, A. ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Vandelli, L. ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Coutinho, J.M. ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Groot, A.E. ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Padjen, V. ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Jovanovic, D.R. ) ) ) [24] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bejot, Y. ) ) ) [25] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Brenière, C. ) ) ) [26] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Turc, G. ) ) ) [27] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Seners, P. ) ) ) [28] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pezzini, A. ) ) ) [29] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Magoni, M. ) ) ) [30] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Leys, D. ) ) ) [31] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gilliot, S. ) ) ) [32] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Scherrer, M.J. ) ) ) [33] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kägi, G. ) ) ) [34] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Luft, A.R. ) ) ) [35] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gensicke, H. ) ) ) [36] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nederkoorn, P. ) ) ) [37] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tatlisumak, T. ) ) ) [38] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Engelter, S.T. ) ) ) [39] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wegener, S. ) ) ) [40] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Thrombolysis in Ischemic Stroke Patients (TRISP) Study Group ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2020 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 00283878 ) [1] => Array ( [Type] => issn-locals [Value] => edsbas ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Neurology, vol. 95, no. 4, pp. e362-e373 [Type] => main ) ) ) ) ) ) )
IllustrationInfo